InDex Pharmaceuticals Holding AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 97.51 million. Revenue was SEK 97.51 million compared to SEK 47.89 million a year ago.

Net loss was SEK 95.27 million compared to SEK 100.33 million a year ago. Basic loss per share from continuing operations was SEK 0.18 compared to SEK 0.19 a year ago.